University of Leipzig spinout C-Lecta has agreed to an acquisition by Kerry, giving it access to additional markets.

Thomas Pfaadt, chief financial officer and managing director, and Marc Struhalla, CEO and managing director of C-Lecta (Photo: C-Lecta)

C-Lecta, a Germany-based enzyme engineering and bioprocess developer spun out of University of Leipzig, has agreed to an acquisition by food group Kerry for €137m ($155m).

The deal will give Kerry a 92% stake in the business, with the remainder held by C-Lecta’s management. The sum paid by Kerry remains subject to closing adjustments.

C-Lecta specialises in precision fermentation, optimised bioprocessing and biotransformation to create high-value, targeted enzymes and ingredients for consumer segments including food and beverage.

The deal with Kerry will give it access to additional markets, while Kerry will benefit from C-Lecta’s technology capabilities.

Marc Struhalla, founder and chief executive of C-Lecta, said: “We are very happy to join Kerry Group and their global presence in the food…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).